Galectin Therapeutics
GALT
GALT
78 hedge funds and large institutions have $23.9M invested in Galectin Therapeutics in 2020 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 18 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
1.21% more ownership
Funds ownership: 17.65% → 18.87% (+1.2%)
11% less capital invested
Capital invested by funds: $26.9M → $23.9M (-$2.96M)
Holders
78
Holding in Top 10
–
Calls
$436K
Puts
$368K
Top Buyers
| 1 | +$888K | |
| 2 | +$213K | |
| 3 | +$184K | |
| 4 |
OSAM
O'Shaughnessy Asset Management
Stamford,
Connecticut
|
+$162K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$135K |
Top Sellers
| 1 | -$194K | |
| 2 | -$138K | |
| 3 | -$126K | |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$74K |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$72K |